[Federal Register Volume 84, Number 181 (Wednesday, September 18, 2019)]
[Notices]
[Pages 49110-49111]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20180]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee (CLIAC);
Correction
Notice is hereby given of a change in the meeting of the Clinical
Laboratory Improvement Advisory Committee (CLIAC); November 6, 2019,
8:30 a.m. to 5:00 p.m., EST and November 7, 2019, 8:30 a.m. to 12:00
p.m., EST which was published in the Federal Register on
[[Page 49111]]
August 30, 2019, Volume 84, Number 169, pages 45765-45766.
The MATTERS TO BE CONSIDERED should read as follows: The agenda
will include agency updates from CDC, the Centers for Medicare and
Medicaid Services (CMS); and the Food and Drug Administration (FDA).
Presentations and discussions will focus on a follow up on CLIAC
recommendations; an update on the clinical laboratory workforce;
improving integration of laboratory information systems with electronic
health records; and future CLIAC topics. There will be an extended
public comment session focusing on emerging technologies and the
clinical laboratory. Agenda items are subject to change as priorities
dictate.
FOR FURTHER INFORMATION CONTACT: Nancy Anderson, MMSc, MT(ASCP), Senior
Advisor for Clinical Laboratories, Division of Laboratory Systems,
Center for Surveillance, Epidemiology and Laboratory Services, Office
of Public Health Scientific Services, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia
30329-4027, telephone (404) 498-2741; [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-20180 Filed 9-17-19; 8:45 am]
BILLING CODE 4163-18-P